April 17th 2025
How to maximize market-entry performance for new pharma products in an increasingly competitive launch environment.
April 15th 2025
Why a fundamental rethinking of how manufacturers engage with healthcare providers, payers, and patients is necessary in today's pharma landscape.
April 14th 2025
The Verseon CEO discusses how this advanced technology is helping to discover new drug candidates.
April 10th 2025
As the physical products we use evolve to become increasingly complex, traditional products liability frameworks may not always fit to provide remedies for harm that can result from using novel product types.
April 9th 2025
Hyfe’s CEO discusses the importance of DTx and how it can change the way certain conditions are treated.
Pfizer Announces PCSK9 Competitive Grants Program
The grants will be offered to investigators conducting research in the field of PCSK9 biology.
Mylan Offers $29 Billion for Perrigo
Mylan announces that it would offer Perrigo $29 billion in cash and stock to buy the Irish company.
Diverse Pipeline "Could Transform Liver Cancer Treatment" Within 10 Years
April 7, 2015.
Novartis and Juno Settle Over CAR-T Therapy Technology
Novartis will make payments to Juno to settle a patent dispute covering chimeric antigen receptor T-cell (CAR-T) therapies.
GSK Announces US Vaccine R&D Center
GlaxoSmithKline announces global vaccines research and design facility to be based in Rockville, MD, USA.
More Incentives for Antibacterial R&D
March 31, 2015.
Five Indispensable Lessons from SXSW
Janelle Starr was surprised to find this month's SXSW speakers talk about failure. But their failures are enlightening, and essential to their ultimate success.
Is the Cost of Drug Development "Accurate"?
March 20, 2015.
ASCO Report Shows Widespread Disturbance in Oncology Practice
18 March, 2015.
PPACA to Help Drive US Pharma Market to $550 Billion by 2020
March 17, 2015.
Valeant Raises Offer for Salix
16 March, 2015.
UK Life Sciences Sector Sees "Resurgence" in Financing
March 16, 2015.
23andMe Adds Therapeutics Unit
$10 Sovaldi on Sale in Bangladesh
March 12. 2015.
India’s Hetero to Launch Sofosbuvir at $11.36/Pill
March 12, 2015.
UK Pharma U-turn on Management Consultants
March 11, 2015.
Five-Year Peak Sales Forecast of Newly Reimbursed Drugs in Japan Surges to $34bn
Indian High Court Clears $4 BN Sun-Ranbaxy Merger
March 10, 2015.
UK BioIndustry Association Calls for Stronger Technology Transfer Measures
March 6, 2015.
FDA Approves First Biosimiar Product in US
6 March, 2015.
AbbVie to Buy Pharmacyclics for $21 Billion
March 5, 2015.
US Judge Blocks Ranbaxy Launch Bid
March 3, 2015.
Targeted Lung Cancer Therapies Supplanting Conventional Treatments, Says Report
Tepid Growth to Put Japan's Pharma Market at $80 Billion by 2020
February 26, 2015.
Former Bayer Chief Brandicourt Appointed Next Sanofi CEO
23 February, 2015.
EMA Establishes Drug Identification Task Force
Indian Drug Agency to Control Medical Devices
February 19, 2015.
Chinese Colorectal Cancer Market to Exceed $1 Billion by 2023
February 18, 2015.
Insomnia Treatment Market Faces Steep Decline
February 17, 2015.
Eastern Europe Top Region for Healthcare Investments